New Data from University of Arkansas for Medical Sciences Illuminate Findings in Tuberous Sclerosis (Evolving Treatment Strategies for Early-life Seizures In Tuberous Sclerosis Complex: a Review and Treatment Algorithm).

A recent study from the University of Arkansas for Medical Sciences explores evolving treatment strategies for early-life seizures in Tuberous Sclerosis Complex (TSC), a genetic disorder that often manifests with epilepsy in infancy. The research focuses on three newly approved therapies - vigabatrin, everolimus, and cannabidiol - and proposes a treatment algorithm emphasizing early diagnosis and prompt therapy initiation. The study aims to guide clinicians in improving seizure control and developmental outcomes in this vulnerable population. [Extracted from the article]